Acceptance rate:
Time to first decision:
8 days*
Time to first decision with review:
71 days*
Acceptance to publication:
21 days*
Impact Factor (JCR):

Aims and scope

Injury Prevention is the leading journal for public-health-focused injury prevention efforts to reduce the burden of injury in all age groups around the world. This includes understanding of not just the physical factors that contribute to injury but also the behavioural, commercial, political and social influences of injury risk. As an international peer-reviewed journal, it publishes original research, opinion, debate, and special features on the prevention of unintentional, and intentional (violence-related) injuries from a public health perspective, across multiple settings and contexts. It is particularly focussed on: furthering data-driven evidence to inform policy and practice responses; improving understanding of, and perceptions around, risks and the preventability of injuries; and documenting both implementation challenges and success stories to provide robust evidence to demonstrate that injury prevention efforts have real-world impact. Injury Prevention is committed to the publication, discussion, and dissemination of research to academics as well as to the injury prevention practitioner workforce and the general community. Injury Prevention is online only. It is the official journal of the Society for Advancement of Violence and Injury Research (SAVIR). For information about the Injury Prevention Editor-in-Chief Professor Caroline Finch and her editorial team, please refer to the Editorial Board page.

Plan S compliance

Injury Prevention is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

Injury Prevention is owned by BMJ
Publication Model
Subscription; with hybrid open access option
Bi-monthly (online only)
Launch date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Expanded, Social Sciences Citation Index; Current Contents: Clinical Medicine, MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Online ISSN

Journal Statistics 2023

Acceptance rate: 36%
Speed Time to first decision without review (median): 8 days Time to first decision with review (median): 71 days Time from acceptance to publication (median): 21 days
Impact Impact Factor category: Public, Environmental & Occupational Health Impact Factor (JCR): 3.8 Impact Factor rank: 80/207 (SCIE) 5 year Impact Factor: 3.1 Journal Citation Indicator (JCI): 1.01 Eigenfactor: 0.00548 Citescore: 5 Citescore rank: 143/577 Scimago Journal Rank (SJR): 1.317
Reach Total content views: 297,531 Total Altmetric mentions: 1,638
the SF Dora logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the Contact Us page.

For authors

Please refer to the Instructions for Authors


COPE logo with IP member number
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Equator Network logo
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.